Of in ieder geval Nederlanders met eerder bewezen (en doorgemaakte) COVID als zodanig vaccineren.
RT @EricTopol: And another on the same important topic, similar finding: "at least one order of magnitude greater than reported after a con…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/ewZvwIGmhy
Antibody response to first BNT162b2 (Pfizer-BioNTech) dose in previously SARS-CoV-2-infected individuals [Feb 25, 2021] @dr_manisty et al. @TheLancet https://t.co/h6n5cJCo52 #COVID19Vaccine Prior #COVID19 + --> vaccination incr anti-S titres > 140-
RT @AlainChapleGil: Respuesta de #anticuerpos a la primera #dosis de #BNT162b2 en individuos previamente infectados por #SARSCoV2 @TheLanc…
Antibody response to first BNT162b2 (Pfizer-BioNTech) dose in previously SARS-CoV-2-infected individuals [Feb 25, 2021] @dr_manisty et al. @TheLancet https://t.co/h6n5cJCo52 #COVID19Vaccine Prior #COVID19 + --> vaccination incr anti-S titres > 140-fo
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
@FromTheHip8 So, very odd. Having copied the link from the article it still seems to redirect to the rolling feed. You may be able to Google the headline and get to it that way ? It references two Lancet studies. https://t.co/QhqADnutb3 https://t.co/tyttX3
Hay que tener estos estudios en cuenta para poder aplicar las vacunas de manera racional, sobre todo cuando vemos que no "sobran" dosis.
RT @fritsfranssen: After one vaccine dose, those with previous Covid19 have antibody titres higher han reported after a conventional prime-…
2/2 @TheLancet paper; Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals can be found here:https://t.co/H1wTBuEnFN
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
RT @LancetMicrobe: New correspondence in @TheLancet> Antibody response to first #BNT162b2 dose in previously #SARSCoV2-infected individuals…
RT @Elsevier_Es: Respuesta de anticuerpos a la primera dosis de BNT162b2 en individuos previamente infectados por SARS-CoV-2 vía @TheLancet…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/kfZO6CcWoP
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
Sobre #COVID19 @Elsevier_Es
RT @Elsevier_Es: Respuesta de anticuerpos a la primera dosis de BNT162b2 en individuos previamente infectados por SARS-CoV-2 vía @TheLancet…
RT @Elsevier_Es: Respuesta de anticuerpos a la primera dosis de BNT162b2 en individuos previamente infectados por SARS-CoV-2 vía @TheLancet…
Respuesta de anticuerpos a la primera dosis de BNT162b2 en individuos previamente infectados por SARS-CoV-2 vía @TheLancet https://t.co/3lqtC0Xxb6 https://t.co/4l12wOGVtT
RT @celinegounder: Lots of good evidence that people who have SARS-CoV-2 antibodies from PRIOR INFECTION only need ONE dose of the Pfizer v…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @AbraarKaran: “These serological data suggest that for indiv receiving the BNT162b2 mRNA vaccine, a potential approach is to include ser…
RT @AbraarKaran: “These serological data suggest that for indiv receiving the BNT162b2 mRNA vaccine, a potential approach is to include ser…
RT @AbraarKaran: “These serological data suggest that for indiv receiving the BNT162b2 mRNA vaccine, a potential approach is to include ser…
Obvious impact on vaccination strategy - Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/8NiqAkr50z
“These serological data suggest that for indiv receiving the BNT162b2 mRNA vaccine, a potential approach is to include serology testing at or before the time of first vaccination to prioritise use of booster doses for individuals w/ no previous inf” https
RT @DrRickLanman: Lancet article - BioNTech/Pfizer single shot in those who already had CoViD produces antibody levels more than 10x higher…
RT @JccmoonMoon: After mild COVID then first dose vaccine, Ab response is so robust that second dose not needed? Lancet https://t.co/Ge4gaI…
You can read this, it's a study done on this topic https://t.co/8xHlpSrjhQ
@urchilla01 @damilola_MD I think I’ve found it https://t.co/1nIVr8gbJi
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @fritsfranssen: After one vaccine dose, those with previous Covid19 have antibody titres higher han reported after a conventional prime-…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @AlainChapleGil: Respuesta de #anticuerpos a la primera #dosis de #BNT162b2 en individuos previamente infectados por #SARSCoV2 @TheLanc…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/NMpJ7akshP
Great idea @CarlosdelRio7 to determine #SARSCoV2 serostatus prior to giving 2nd #vaccination, but will require an organized healthcare system to test and inform those with evidence of prior infection. Worth piloting in places that have their act together.
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/hjgYV4hGTo
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
RT @TheLancet: Another Correspondence describes similar early findings—previous #COVID19 infection may be comparable to immune priming. Aut…
RT @CarlosdelRio7: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 2…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/pqovR4V0kP. With ~ 20% already infected, should we perform serology at the time of first vaccination to prioritise use of booster doses for individuals with
RT @fritsfranssen: After one vaccine dose, those with previous Covid19 have antibody titres higher han reported after a conventional prime-…
RT @celinegounder: Lots of good evidence that people who have SARS-CoV-2 antibodies from PRIOR INFECTION only need ONE dose of the Pfizer v…
RT @fritsfranssen: After one vaccine dose, those with previous Covid19 have antibody titres higher han reported after a conventional prime-…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @RotherhamNHSLib: Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/YfbFtlAX2o #covi19…
RT @celinegounder: Lots of good evidence that people who have SARS-CoV-2 antibodies from PRIOR INFECTION only need ONE dose of the Pfizer v…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/YfbFtlAX2o #covi19rftlks
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals https://t.co/4KEQgHDRLT
RT @kamleshkhunti: One dose of #PfizerVaccine induces a strong immune response in people who have already had #COVID19 https://t.co/efo2…
Serology data indicates to prioritise use of 2nd dose of vaccine for individuals with no previous infection https://t.co/9us3uO9Xo7 #ExpatNotesLux #COVID19 #Coronavirus #COVID19vaccination @ECDC_EU @sante_lu @ResearchLux @uni_lu @LNS_Lux @LIH_Luxembourg
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
@EspagneLionel @CAudigierValett @Drmartyufml @olivierveran @france2 https://t.co/9dLZhL4T3V Une seule injection semble bien suffire La raison est bien là, en plus d'économiser des doses
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: Lots of good evidence that people who have SARS-CoV-2 antibodies from PRIOR INFECTION only need ONE dose of the Pfizer v…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
Respuesta de #anticuerpos a la primera #dosis de #BNT162b2 en individuos previamente infectados por #SARSCoV2 @TheLancet #COVID19 https://t.co/uvplUy71IH https://t.co/JEd806QOPF
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @celinegounder: More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.c…
RT @DrRickLanman: Lancet article - BioNTech/Pfizer single shot in those who already had CoViD produces antibody levels more than 10x higher…
More data supporting one dose of COVID vaccine among those who've already had COVID: https://t.co/rw0KxdcB5x https://t.co/ivbaObWOZc
RT @DrRickLanman: Lancet article - BioNTech/Pfizer single shot in those who already had CoViD produces antibody levels more than 10x higher…
RT @DrRickLanman: Lancet article - BioNTech/Pfizer single shot in those who already had CoViD produces antibody levels more than 10x higher…
Lancet article - BioNTech/Pfizer single shot in those who already had CoViD produces antibody levels more than 10x higher than someone after 2 vaccine shots. Let's stop wasting 2nd dose on people who don't need it, until all high risk people vaccinated. ht
RT @TheLancet: Another Correspondence describes similar early findings—previous #COVID19 infection may be comparable to immune priming. Aut…
RT @LancetMicrobe: New correspondence in @TheLancet> Antibody response to first #BNT162b2 dose in previously #SARSCoV2-infected individuals…
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
RT @TheLancet: Another Correspondence describes similar early findings—previous #COVID19 infection may be comparable to immune priming. Aut…
@WorkerTrump @alaynatreene Boost immunity higher for better odds of never getting it again, seems like a reason. https://t.co/BqDcS3uWiR
After one vaccine dose, those with previous Covid19 have antibody titres higher han reported after a conventional prime-boost vaccine strategy in previously uninfected individuals. Thus, one dose may be sufficient in those who were previously infected... h
Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection – via @imperialcollege Study 1: https://t.co/ALzwGHdWZ5 Study 2: https://t.co/7pThwRpgDR
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
👇🏻👇🏻👇🏻
RT @davsrodrigues: No Lancet vem uma pequena pérola: pessoas com infecção COVID prévia têm níveis de anticorpos para o SARS-CoV-2 semelhan…
Wellicht kan overbehandeling voorkomen worden door serotologisch onderzoek of iemand al sars-cov2 heeft doorgemaakt? Betere Vaccin strategie, uit de locked down? Interessant artikel. @hommel_b https://t.co/Wfu9l6XPAN
RT @grahamscooke: One from @mkwillicombe @wendybarclay11 @kidneydoc101 &co (https://t.co/lAk6BxNZS0) , the other from @Daltmann10 @mnoursad…
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
RT @KusumiEiji: ファイザーのコロナワクチン1回接種で、自然感染したのと同程度に抗体価が上がる 自然感染した事のある人に1回接種したら、抗体価は140倍に上昇し、このワクチンには自然感染に対するブースター効果のあることが分かった 1回目の接種時に抗体検査を併用…
@petunianelsole Qui si sottolinea lo stesso concetto https://t.co/gp51NmYrua